We follow industry news and trends so you can stay ahead of the game. Subscribe to receive emails regarding policies and findings that impact you and your business.

Already a subscriber and want to update your preferences? Click here.

BACK TO NEWS

MEDIA MENTIONS

OCT 31 2023

FDA Demands Congress Create New Regulatory Pathway for CBD - Cannabis Law and Policy

William Garvin, shareholder and Cannabis practice group leader; Tina Hu-Rodgers, counsel and Life Sciences industry group leader; and Natalie Oehlers, associate in the firm's FDA section coauthored "FDA Demands Congress Create New Regulatory Pathway for CBD" for the American Bar Association's Cannabis Law and Policy publication.